Diagnosis and Treatment of Brugada Syndrome: Review of the Literature
Main Article Content
Abstract
Brugada syndrome is a genetic disorder that causes abnormalities in the correct functioning of the electrical system of the heart, which can end in health complications such as arrythmias, syncope or, in the most severe cases, sudden death. Nowadays, stratification of the risks derived from this disease is still a great challenge due to the disorder's complex nature influenced by several factors. Such investigations have been able to obtain evidence of the role that autonomic imbalance plays in the pathology of the disorder.
Subsequently, a Matlab code inspired by pre-existing algorithms was written, carrying out research on the methods currently used to detect this syndrome, in order to study the different biomarkers obtained through a simple and non-invasive procedure such as the electrocardiogram(EKG). After the study, the length of the QRS complex and the T wave, the absolute area , the RMS amplitude, as well as the length of the QT and QTc segments of each of the patients´ EKGs were measured.
Article Details
This work is licensed under a Creative Commons Attribution 4.0 International License.
References
I. Brugada P, Brugada, J. Right bundle branch block, persistent ST segment elevation and sudden cardiac death: a distinct clinical and electrocardiographic syndrome. A multicenter report. J Am Coll Cardiol. 1992; 20:1391-1396.
II. Antzelevitch C, Brugada P. Brugada syndrome: a decade of progress. Circ Res. 2002; 91:1114-1118.
III. Wilde A, Antzelevitch C, Borggrefe M. Study Group on the Molecular Basis of Arrhythmias of the European Society of Cardiology. Proposed diagnostic criteria for the Brugada syndrome: consensus report. Circulation. 2002; 106:2514-2519.
IV. Antzelevitch Ch, Brugada P, Brugada J. Brugada Syndrome: Report of the Second Consensus Conference. Circulation. 2005; 111:659-670.
V. van den Berg MP, de Boer RA, van Tintelen JP. Brugada syndrome or Brugada electrocardiogram?. J Am Col Cardiol. 2009; 53:1569.
VI. Priori SG, Gasparini M, Napolitano C, et al. Risk stratification in Brugada syndrome: results of the PRELUDE (PRogrammed ELectrical stimUlation preDictive valuE) registry. J Am Coll Cardiol. 2012; 59(1):37-45. doi: 10.1016/j.jacc.2011.08.064
VII. Brugada J, Pappone C. Brugada syndrome phenotype elimination by epicardial substrate ablation. Circ Arrhythm Electrophysiol. 2015; 8(6):1373-81. doi: 10.1161/CIRCEP.115.003220
VIII. Fauchier L, Isorni M. Prognostic value of programmed ventricular stimulation in Brugada syndrome according to clinical presentation: an updated meta- analysis of worldwide published data. Int J Cardiol. 2013; 168:3027-9.
IX. Gehi A, Duong T. Risk stratification of individuals with the Brugada electrocardiogram: a meta-analysis. J Cardiovasc Electrophysiol. 2006; 17:577–83.
X. Ackerman M, Priori S. HRS/EHRA expert consensus statement on the state of genetic testing for the channelopathies and cardiomyopathies. Europace. 2011; 13:1077–109.
XI. Priori SG, Wilde AA, Horie M, et al. HRS/EHRA/ APHRS expert consensus statement on the diagnosis and management of patients with inherited primary arrhythmia syndromes: document endorsed by HRS, EHRA, and APHRS in May 2013 and by ACCF, AHA, PACES, and AEPC in June 2013. Heart Rhythm. 2013;10(12):1932-63.
doi: 10.1016/j.hrthm.2013.05. 014
XII. Miyamoto K, Yokokawa M. Diagnostic and prognostic value of a type I Brugada electrocardiogram at higher (third or second) V1 to V2 recording in men with Brugada syndrome. Am J Cardiol. 2007; 99:53- 57.
XIII. Antzelevitch C, Yan GX, Ackerman MJ, et al. J-Wave syndromes expert consensus conference report: Emerging concepts and gaps in knowledge. Europace. 2017; 19(4):665-694. doi: 10.1093/ europace/euw235.
XIV. Miranda D, Medina F, Salinas J. Síndrome de Brugada: Reporte de un caso y revisión de la literatura.